Mycosynthesis, characterization and antibacterial properties of AgNPs against multidrug resistant (MDR) bacterial pathogens of female infertility cases

Asian Journal of Pharmaceutical Sciences

Volumn 10, Issue 2, 2015, Pages 138-145

  Gopinath, Ponnusamy Manogaran ^a   Narchonai, Ganesan ^a   Dhanasekaran, Dharumadurai ^a   Ranjani, Anandan ^a   Thajuddin, Nooruddin ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

Author keywords

AgNPs Ampicillin complex; Fusarium oxysporum; Infertility; Multidrug resistance; Silver nanoparticles

Indexed keywords

AMPICILLIN; SILVER NANOPARTICLE;

AGARICUS BISPORUS; ALTERNARIA ALTERNATA; ANTIBACTERIAL ACTIVITY; ARTICLE; ASPERGILLUS TERREUS; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; ENTEROBACTER; ESCHERICHIA COLI; FEMALE INFERTILITY; FUSARIUM ACUMINATUM; FUSARIUM OXYSPORUM; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; PARTICLE SIZE; PENICILLIN RESISTANCE; PHYTOPHTHORA INFESTANS; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; SURFACE PLASMON RESONANCE; TURBIDIMETRY; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION;

EID: 84925849705     PISSN: 18180876     EISSN: 2221285X     Source Type: Journal    
DOI: 10.1016/j.ajps.2014.08.007     Document Type: Article

References (43)

1. Comhaire F.H., Mahmoud A.M.A., Depuydt C.E., et al. Mechanisms and effects of male genital tract infection on sperm quality and fertilizing potential: the andrologist's viewpoint. Hum Reprod Update 1999, 5:393-398.
2. Khalili M.B., Sharifi-Yazdi M.K. The effect of bacterial infection on the quality of humanâs spermatozoa. Iranian J Pub Health 2001, 35:62-67.
3. Anchana Devi C., Ranjani A., Dhanasekaran D., et al. Surveillance of multidrug resistant bacteria pathogens from female infertility cases. Afr J Biotechnol 2013, 12:4129-4134.
4. Kim J.S., Kuk E., Yu K.N., et al. Antimicrobial effects of silver nanoparticles. Nanomed Nanotech Biol Med 2007, 3:95-101.
5. Morones J.R., Elechiguerra J.L., Camacho A., et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346-2353.
6. Schabes-Retchkiman P.S., Canizal G., Herrera-Becerra R., et al. Biosynthesis and characterization of Ti/Ni bimetallic nanoparticles. Opt Mater 2006, 29:95-99.
7. Gu H., Ho P.L., Tong E., et al. Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Lett 2003, 3:1261-1263.
8. Dhanasekaran D., Latha S., Saha S., et al. Biosynthesis and antimicrobial potential of metal nanoparticles. Int J Green Nanotechnol 2011, 3:72-82.
9. Dhanasekaran D., Latha S., Saha S., et al. Extracellular biosynthesis, characterisation and in-vitro antibacterial potential of silver nanoparticles using Agaricus bisporus. J Exp Nanosci 2013, 8:579-588.
10. 4@ Ag nanoparticles. Nanotechnology 2007, 18:604-611.
11. Marambio-Jones C., Hoek E.M.V. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res 2010, 12:1531-1551.
12. Duran N., Marcato P.D., Alves O.L., et al. Mechanistic aspects of biosynthesis of silver nanoparticles by several Fusarium oxysporum strains. J Nanobiotechnology 2005, 3:1-7.
13. Ingle A., Gade A., Pierrat S., et al. Mycosynthesis of silver nanoparticles using the fungus Fusarium acuminatum and its activity against some human pathogenic bacteria. Curr Nanosci 2008, 4:141-144.
14. Gade A.K., Bonde P., Ingle A.P., et al. Exploitation of Aspergillus niger for synthesis of silver nanoparticles. J Biobased Mater Bio 2008, 2:243-247.
15. Pal S., Tak Y.K., Song J.M. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 2007, 73:1712-1720.
16. Gherbawy Y.A., Shalaby I.M., El-sadek M.S.A., et al. The anti-fasciolasis properties of silver nanoparticles produced by Trichoderma harzianum and their improvement of the anti-fasciolasis drug triclabendazole. Int J Mol Sci 2013, 14:21887-21898.
17. Li Y., Duan X., Qian Y., et al. Nanocrystalline silver particles: synthesis, agglomeration, and sputtering induced by electron beam. J Colloid Interface Sci 1999, 209:347-349.
18. Ahmad A., Mukherjee P., Senapati S., et al. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Colloid Surf B 2003, 28:313-318.
19. Kathiresan K., Manivannan S., Nabeel M.A., et al. Studies on silver nanoparticles synthesized by a marine fungus, Penicillium fellutanum isolated from coastal mangrove sediment. Colloid Surf B 2009, 71:133-137.
20. Thirumurugan G., Shaheedha S.M., Dhanaraju M.D. Invitro evaluation of antibacterial activity of silver nanoparticles synthesised by using Phytophthora infestans. Int J ChemTech Res 2009, 1:714-716.
21. Gajbhiye M., Kesharwani J., Ingle A., et al. Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole. Nanomed Nanotech Biol Med 2009, 5:382-386.
22. Dhanasekaran D., Thangaraj R. Evaluation of larvicidal activity of biogenic nanoparticles against filariasis causing Culex mosquito vector. Asian Pac J Trop Dis 2013, 3:174-179.
23. Saha S., Sarkar J., Chattopadhyay D., et al. Production of silver nanoparticles by a phytopathogenic fungus Bipolaris nodulosa and its antimicrobial activity. Dig J Nanomater Biostruct 2010, 5:887-895.
24. Kalishwaralal K., Deepak V., Ramkumarpandian S., et al. Extracellular biosynthesis of silver nanoparticles by the culture supernatant of Bacillus licheniformis. Mater Lett 2008, 62:4411-4413.
25. Serratosa J.M., Johns W.D., Shimoyama A. IR study of alkylammonium vermiculite complexes. Clay Clay Miner 1970, 18:113.
26. Peniche C., Arguelles-Monal W., Davidenko N., et al. Self-curing membranes of chitosan/PAA IPNs obtained by radical polymerization: preparation, characterization and interpolymer complexation. Biomaterials 1999, 20:1869-1878.
27. Ahmad I., Jie M.S.F.L.K. Oleochemicals from isoricinoleic acid (Wrightia tinctoria seed oil). Ind Eng Chem Res 2008, 47:2091-2095.
28. Galande C., Mohite A.D., Naumov A.V., et al. Quasi-molecular fluorescence from graphene oxide. Sci Rep 2011, 1:1-5.
29. Bright A., Devi T.S.R., Gunasekaran S. Spectroscopical vibrational band assignment and qualitative analysis of biomedical compounds with cardiovascular activity. Int J Chem Tech Res 2010, 2:379-388.
30. Hodzic I.M., Niketic S.R. Synthesis and characterization of a novel (glycinato-N, O) yttrium (III) complex. J Serb Chem Soc 2001, 66:331-334.
31. Malekfar R., Daraei A. Raman scattering and electrical properties of TGS: PCo (9%) crystal as ambient temperature IR detector. Acta Phys Pol A Gen Phys 2008, 114:859.
32. 2 in single-walled carbon nanotubes during thermal treatment. J Phys Chem B 2004, 108:19949-19954.
33. 2 by Xe in single-walled carbon nanotube bundles. Phys Rev B 2004, 70:165416.
34. Balaji D.S., Basavaraja S., Deshpande R., et al. Extracellular biosynthesis of functionalized silver nanoparticles by strains of Cladosporium cladosporioides fungus. Colloid Surf B 2009, 68:88-92.
35. Mandal S., Gole A., Lala N., et al. Studies on the reversible aggregation of cysteine-capped colloidal silver particles interconnected via hydrogen bonds. Langmuir 2001, 17:6262-6268.
36. Shaligram N.S., Bule M., Bhambure R., et al. Biosynthesis of silver nanoparticles using aqueous extract from the compactin producing fungal strain. Process Biochem 2009, 44:939-943.
37. Feng Q.L., Wu J., Chen G.Q., et al. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 2000, 52:662-668.
38. Guggenbichler J.P. The Erlanger silver catheter: invitro results for antimicrobial activity. J Infect 1999, 27:S24-S29.
39. Davies R.L., Etris S.F. The development and functions of silver in water purification and disease control. Catal Today 1997, 36:107-114.
40. Yamanaka M., Hara K., Kudo J. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol 2005, 71:7589-7593.
41. Klueh U., Wagner V., Kelly S., et al. Efficacy of silver-coated fabric to prevent bacterial.colonization and subsequent device-based biofilm formation. J Biomed Mater Res 2000, 53:621-631.
42. Fox C.L., Modak S.M. Mechanism of silver sulfadiazine action on burn wound infections. Antimicrob Agents Chemother 1974, 5:582-588.
43. Brown A.N., Smith K., Samuels T.A., et al. Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus. Appl Environ Microbiol 2012, 78:2768-2774.